The factors that are driving the global Epilepsy drug market are increasing epilepsy prevalence, growing patient awareness programs, government funding and drugs reimbursement options in European & American countries

Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$ 9 Billion landmark by 2025. 


Epilepsy can develop in both males and females of all races, ethnic backgrounds and ages. It affects around 65 Million people globally. United States has around 3.4 Million epilepsy patients; among them around 470 Thousands are children. Epilepsy prevalence varies across various parts of the world. At present, nearly one-third of the total patients are suffering from uncontrollable seizures and are not able to get treatment because no available treatment works for them. 


Renub Research report titled “Epilepsy Drugs Market by Country (United States, United Kingdom, France, Germany, Italy, Spain, India, China, Japan), Drugs [(Vimpat (Lacosamide), Keppra (Levetiracetam), Sabril (Vigabatrin), Onfi (Clobazam), Fycompa, Briviact (Brivaracetam), Epidiolex, Cenobamate (YKP3089)], Treatment Drugs Generation (First, Second, Third), Company (Eisai Co., Ltd, UCB Inc., H. Lundbeck A/S, GW Pharmaceuticals Plc.) & Forecast” provides a complete analysis of Global Epilepsy Drugs Market. This report also covers all-encompassing analysis of the key growth drivers and challenges, market trends, key players and their projections for the future.




Key Topics Covered :

1.    Introduction
2.    Research Methodology
3.    Executive Summary
4.    Global Epilepsy Drugs Market (2013 – 2025)
5.    Market Share – Global Epilepsy Drugs (2013 – 2025)
6.    Country - Global Epilepsy Drugs Market Analysis (2013 – 2025)
7.    By Drugs Category - Global Epilepsy Drugs Market Analysis (2013 – 2025)
8.    By Drugs - Global Epilepsy Drugs Market Analysis (2013 – 2025)
9.    Growth Drivers
10.    Challenges
11.    Eisai Co., Ltd.
12.    UCB Inc.
13.    H. Lundbeck A/S
14.    GW Pharmaceuticals Plc.


About Us

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Media Contact
Company Name: Renub Research
Contact Person: Rajat Gupta
Email: Send Email
Phone: +1-678-302-0700
Address:225 Kristie Ln 
City: Roswell
State: Georgia 
Country: United States
Website: www.renub.com/drugs-and-pharmaceuticals-13-c.php

Comments